Salvage high-dose-rate brachytherapy for recurrent prostate cancer

Background. Prostate cancer (PCa) is one of the most common malignant diseases in men worldwide, with over 1.1 million cases of PCa reported annually. In the Russian Federation, the proportion of patients with stage I—II PCa from 2008 to 2018 increased from 37.6 % to 56 %, which in turn allows more...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A. D. Kaprin, S. A. Ivanov, O. B. Karyakin, A. A. Obuhov, V. A. Biryukov, N. B. Borysheva, D. B. Sanin, O. G. Lepilina, A. L. Smolkin, A. V. Dem’yanovich, N. G. Minaeva, N. V. Mikhaylovskiy
Formato: Artigo
Idioma:Russo
Publicado em: ABV-press 2020-12-01
Colecção:Onkourologiâ
Assuntos:
prostate cancer
recurrent prostate cancer
prostate-specific antigen
salvage brachytherapy
high-dose-rate brachytherapy
interstitial radiotherapy
Acesso em linha:https://oncourology.abvpress.ru/oncur/article/view/1316
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados